Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

INMACULADA CONCEPCIÓN HERRERA ARROYO2026-01-292026-01-29202210.3389/fimmu.2022.10118582-s2.0-85140352989https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/35589ImmunologyImmunology and AllergyEfficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphomaresearch article